Global Self-amplifying RNA (saRNA) Drugs Supply, Demand and Key Producers, 2024-2030
The global Self-amplifying RNA (saRNA) Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
saRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
This report studies the global Self-amplifying RNA (saRNA) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Self-amplifying RNA (saRNA) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self-amplifying RNA (saRNA) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Self-amplifying RNA (saRNA) Drugs total production and demand, 2019-2030, (K Units)
Global Self-amplifying RNA (saRNA) Drugs total production value, 2019-2030, (USD Million)
Global Self-amplifying RNA (saRNA) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Self-amplifying RNA (saRNA) Drugs domestic production, consumption, key domestic manufacturers and share
Global Self-amplifying RNA (saRNA) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Self-amplifying RNA (saRNA) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna and CSL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self-amplifying RNA (saRNA) Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Self-amplifying RNA (saRNA) Drugs Market, By Region:
1. How big is the global Self-amplifying RNA (saRNA) Drugs market?
2. What is the demand of the global Self-amplifying RNA (saRNA) Drugs market?
3. What is the year over year growth of the global Self-amplifying RNA (saRNA) Drugs market?
4. What is the production and production value of the global Self-amplifying RNA (saRNA) Drugs market?
5. Who are the key producers in the global Self-amplifying RNA (saRNA) Drugs market?
saRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5' cap, a 3' poly(A) tail, and 5' and 3' UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
This report studies the global Self-amplifying RNA (saRNA) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Self-amplifying RNA (saRNA) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self-amplifying RNA (saRNA) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Self-amplifying RNA (saRNA) Drugs total production and demand, 2019-2030, (K Units)
Global Self-amplifying RNA (saRNA) Drugs total production value, 2019-2030, (USD Million)
Global Self-amplifying RNA (saRNA) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Self-amplifying RNA (saRNA) Drugs domestic production, consumption, key domestic manufacturers and share
Global Self-amplifying RNA (saRNA) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-amplifying RNA (saRNA) Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Self-amplifying RNA (saRNA) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna and CSL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self-amplifying RNA (saRNA) Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Self-amplifying RNA (saRNA) Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Preventive Medicine
- Medicine
- Infectious Disease
- Cancer
- Others
- Chimeron Bio
- Ziphius Vaccines
- Aldevron
- VaxEquity
- Precision Nanosystems
- Replicate Bioscience
- Elixirgen Therapeutics
- Immorna
- CSL
- Arcturus Therapeutics
1. How big is the global Self-amplifying RNA (saRNA) Drugs market?
2. What is the demand of the global Self-amplifying RNA (saRNA) Drugs market?
3. What is the year over year growth of the global Self-amplifying RNA (saRNA) Drugs market?
4. What is the production and production value of the global Self-amplifying RNA (saRNA) Drugs market?
5. Who are the key producers in the global Self-amplifying RNA (saRNA) Drugs market?
1 SUPPLY SUMMARY
1.1 Self-amplifying RNA (saRNA) Drugs Introduction
1.2 World Self-amplifying RNA (saRNA) Drugs Supply & Forecast
1.2.1 World Self-amplifying RNA (saRNA) Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.2.3 World Self-amplifying RNA (saRNA) Drugs Pricing Trends (2019-2030)
1.3 World Self-amplifying RNA (saRNA) Drugs Production by Region (Based on Production Site)
1.3.1 World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019-2030)
1.3.2 World Self-amplifying RNA (saRNA) Drugs Production by Region (2019-2030)
1.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2019-2030)
1.3.4 North America Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.5 Europe Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.6 China Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.7 Japan Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Self-amplifying RNA (saRNA) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Self-amplifying RNA (saRNA) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Self-amplifying RNA (saRNA) Drugs Demand (2019-2030)
2.2 World Self-amplifying RNA (saRNA) Drugs Consumption by Region
2.2.1 World Self-amplifying RNA (saRNA) Drugs Consumption by Region (2019-2024)
2.2.2 World Self-amplifying RNA (saRNA) Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.4 China Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.5 Europe Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.6 Japan Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.7 South Korea Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.8 ASEAN Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.9 India Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
3 WORLD SELF-AMPLIFYING RNA (SARNA) DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Self-amplifying RNA (saRNA) Drugs Production Value by Manufacturer (2019-2024)
3.2 World Self-amplifying RNA (saRNA) Drugs Production by Manufacturer (2019-2024)
3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturer (2019-2024)
3.4 Self-amplifying RNA (saRNA) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Self-amplifying RNA (saRNA) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Self-amplifying RNA (saRNA) Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Self-amplifying RNA (saRNA) Drugs in 2023
3.6 Self-amplifying RNA (saRNA) Drugs Market: Overall Company Footprint Analysis
3.6.1 Self-amplifying RNA (saRNA) Drugs Market: Region Footprint
3.6.2 Self-amplifying RNA (saRNA) Drugs Market: Company Product Type Footprint
3.6.3 Self-amplifying RNA (saRNA) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Comparison
4.1.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Comparison
4.2.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Comparison
4.3.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
4.5 China Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share
4.5.1 China Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
4.6 Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Self-amplifying RNA (saRNA) Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Preventive Medicine
5.2.2 Medicine
5.3 Market Segment by Type
5.3.1 World Self-amplifying RNA (saRNA) Drugs Production by Type (2019-2030)
5.3.2 World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2019-2030)
5.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Self-amplifying RNA (saRNA) Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Infectious Disease
6.2.2 Cancer
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Self-amplifying RNA (saRNA) Drugs Production by Application (2019-2030)
6.3.2 World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2019-2030)
6.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Chimeron Bio
7.1.1 Chimeron Bio Details
7.1.2 Chimeron Bio Major Business
7.1.3 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product and Services
7.1.4 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Chimeron Bio Recent Developments/Updates
7.1.6 Chimeron Bio Competitive Strengths & Weaknesses
7.2 Ziphius Vaccines
7.2.1 Ziphius Vaccines Details
7.2.2 Ziphius Vaccines Major Business
7.2.3 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product and Services
7.2.4 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Ziphius Vaccines Recent Developments/Updates
7.2.6 Ziphius Vaccines Competitive Strengths & Weaknesses
7.3 Aldevron
7.3.1 Aldevron Details
7.3.2 Aldevron Major Business
7.3.3 Aldevron Self-amplifying RNA (saRNA) Drugs Product and Services
7.3.4 Aldevron Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Aldevron Recent Developments/Updates
7.3.6 Aldevron Competitive Strengths & Weaknesses
7.4 VaxEquity
7.4.1 VaxEquity Details
7.4.2 VaxEquity Major Business
7.4.3 VaxEquity Self-amplifying RNA (saRNA) Drugs Product and Services
7.4.4 VaxEquity Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 VaxEquity Recent Developments/Updates
7.4.6 VaxEquity Competitive Strengths & Weaknesses
7.5 Precision Nanosystems
7.5.1 Precision Nanosystems Details
7.5.2 Precision Nanosystems Major Business
7.5.3 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product and Services
7.5.4 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Precision Nanosystems Recent Developments/Updates
7.5.6 Precision Nanosystems Competitive Strengths & Weaknesses
7.6 Replicate Bioscience
7.6.1 Replicate Bioscience Details
7.6.2 Replicate Bioscience Major Business
7.6.3 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product and Services
7.6.4 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Replicate Bioscience Recent Developments/Updates
7.6.6 Replicate Bioscience Competitive Strengths & Weaknesses
7.7 Elixirgen Therapeutics
7.7.1 Elixirgen Therapeutics Details
7.7.2 Elixirgen Therapeutics Major Business
7.7.3 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
7.7.4 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Elixirgen Therapeutics Recent Developments/Updates
7.7.6 Elixirgen Therapeutics Competitive Strengths & Weaknesses
7.8 Immorna
7.8.1 Immorna Details
7.8.2 Immorna Major Business
7.8.3 Immorna Self-amplifying RNA (saRNA) Drugs Product and Services
7.8.4 Immorna Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Immorna Recent Developments/Updates
7.8.6 Immorna Competitive Strengths & Weaknesses
7.9 CSL
7.9.1 CSL Details
7.9.2 CSL Major Business
7.9.3 CSL Self-amplifying RNA (saRNA) Drugs Product and Services
7.9.4 CSL Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 CSL Recent Developments/Updates
7.9.6 CSL Competitive Strengths & Weaknesses
7.10 Arcturus Therapeutics
7.10.1 Arcturus Therapeutics Details
7.10.2 Arcturus Therapeutics Major Business
7.10.3 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
7.10.4 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Arcturus Therapeutics Recent Developments/Updates
7.10.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Self-amplifying RNA (saRNA) Drugs Industry Chain
8.2 Self-amplifying RNA (saRNA) Drugs Upstream Analysis
8.2.1 Self-amplifying RNA (saRNA) Drugs Core Raw Materials
8.2.2 Main Manufacturers of Self-amplifying RNA (saRNA) Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Self-amplifying RNA (saRNA) Drugs Production Mode
8.6 Self-amplifying RNA (saRNA) Drugs Procurement Model
8.7 Self-amplifying RNA (saRNA) Drugs Industry Sales Model and Sales Channels
8.7.1 Self-amplifying RNA (saRNA) Drugs Sales Model
8.7.2 Self-amplifying RNA (saRNA) Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Self-amplifying RNA (saRNA) Drugs Introduction
1.2 World Self-amplifying RNA (saRNA) Drugs Supply & Forecast
1.2.1 World Self-amplifying RNA (saRNA) Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.2.3 World Self-amplifying RNA (saRNA) Drugs Pricing Trends (2019-2030)
1.3 World Self-amplifying RNA (saRNA) Drugs Production by Region (Based on Production Site)
1.3.1 World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019-2030)
1.3.2 World Self-amplifying RNA (saRNA) Drugs Production by Region (2019-2030)
1.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2019-2030)
1.3.4 North America Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.5 Europe Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.6 China Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.3.7 Japan Self-amplifying RNA (saRNA) Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Self-amplifying RNA (saRNA) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Self-amplifying RNA (saRNA) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Self-amplifying RNA (saRNA) Drugs Demand (2019-2030)
2.2 World Self-amplifying RNA (saRNA) Drugs Consumption by Region
2.2.1 World Self-amplifying RNA (saRNA) Drugs Consumption by Region (2019-2024)
2.2.2 World Self-amplifying RNA (saRNA) Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.4 China Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.5 Europe Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.6 Japan Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.7 South Korea Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.8 ASEAN Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
2.9 India Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030)
3 WORLD SELF-AMPLIFYING RNA (SARNA) DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Self-amplifying RNA (saRNA) Drugs Production Value by Manufacturer (2019-2024)
3.2 World Self-amplifying RNA (saRNA) Drugs Production by Manufacturer (2019-2024)
3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturer (2019-2024)
3.4 Self-amplifying RNA (saRNA) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Self-amplifying RNA (saRNA) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Self-amplifying RNA (saRNA) Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Self-amplifying RNA (saRNA) Drugs in 2023
3.6 Self-amplifying RNA (saRNA) Drugs Market: Overall Company Footprint Analysis
3.6.1 Self-amplifying RNA (saRNA) Drugs Market: Region Footprint
3.6.2 Self-amplifying RNA (saRNA) Drugs Market: Company Product Type Footprint
3.6.3 Self-amplifying RNA (saRNA) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Comparison
4.1.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Comparison
4.2.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Comparison
4.3.1 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
4.5 China Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share
4.5.1 China Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
4.6 Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Self-amplifying RNA (saRNA) Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Preventive Medicine
5.2.2 Medicine
5.3 Market Segment by Type
5.3.1 World Self-amplifying RNA (saRNA) Drugs Production by Type (2019-2030)
5.3.2 World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2019-2030)
5.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Self-amplifying RNA (saRNA) Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Infectious Disease
6.2.2 Cancer
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Self-amplifying RNA (saRNA) Drugs Production by Application (2019-2030)
6.3.2 World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2019-2030)
6.3.3 World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Chimeron Bio
7.1.1 Chimeron Bio Details
7.1.2 Chimeron Bio Major Business
7.1.3 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product and Services
7.1.4 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Chimeron Bio Recent Developments/Updates
7.1.6 Chimeron Bio Competitive Strengths & Weaknesses
7.2 Ziphius Vaccines
7.2.1 Ziphius Vaccines Details
7.2.2 Ziphius Vaccines Major Business
7.2.3 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product and Services
7.2.4 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Ziphius Vaccines Recent Developments/Updates
7.2.6 Ziphius Vaccines Competitive Strengths & Weaknesses
7.3 Aldevron
7.3.1 Aldevron Details
7.3.2 Aldevron Major Business
7.3.3 Aldevron Self-amplifying RNA (saRNA) Drugs Product and Services
7.3.4 Aldevron Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Aldevron Recent Developments/Updates
7.3.6 Aldevron Competitive Strengths & Weaknesses
7.4 VaxEquity
7.4.1 VaxEquity Details
7.4.2 VaxEquity Major Business
7.4.3 VaxEquity Self-amplifying RNA (saRNA) Drugs Product and Services
7.4.4 VaxEquity Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 VaxEquity Recent Developments/Updates
7.4.6 VaxEquity Competitive Strengths & Weaknesses
7.5 Precision Nanosystems
7.5.1 Precision Nanosystems Details
7.5.2 Precision Nanosystems Major Business
7.5.3 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product and Services
7.5.4 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Precision Nanosystems Recent Developments/Updates
7.5.6 Precision Nanosystems Competitive Strengths & Weaknesses
7.6 Replicate Bioscience
7.6.1 Replicate Bioscience Details
7.6.2 Replicate Bioscience Major Business
7.6.3 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product and Services
7.6.4 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Replicate Bioscience Recent Developments/Updates
7.6.6 Replicate Bioscience Competitive Strengths & Weaknesses
7.7 Elixirgen Therapeutics
7.7.1 Elixirgen Therapeutics Details
7.7.2 Elixirgen Therapeutics Major Business
7.7.3 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
7.7.4 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Elixirgen Therapeutics Recent Developments/Updates
7.7.6 Elixirgen Therapeutics Competitive Strengths & Weaknesses
7.8 Immorna
7.8.1 Immorna Details
7.8.2 Immorna Major Business
7.8.3 Immorna Self-amplifying RNA (saRNA) Drugs Product and Services
7.8.4 Immorna Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Immorna Recent Developments/Updates
7.8.6 Immorna Competitive Strengths & Weaknesses
7.9 CSL
7.9.1 CSL Details
7.9.2 CSL Major Business
7.9.3 CSL Self-amplifying RNA (saRNA) Drugs Product and Services
7.9.4 CSL Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 CSL Recent Developments/Updates
7.9.6 CSL Competitive Strengths & Weaknesses
7.10 Arcturus Therapeutics
7.10.1 Arcturus Therapeutics Details
7.10.2 Arcturus Therapeutics Major Business
7.10.3 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
7.10.4 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Arcturus Therapeutics Recent Developments/Updates
7.10.6 Arcturus Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Self-amplifying RNA (saRNA) Drugs Industry Chain
8.2 Self-amplifying RNA (saRNA) Drugs Upstream Analysis
8.2.1 Self-amplifying RNA (saRNA) Drugs Core Raw Materials
8.2.2 Main Manufacturers of Self-amplifying RNA (saRNA) Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Self-amplifying RNA (saRNA) Drugs Production Mode
8.6 Self-amplifying RNA (saRNA) Drugs Procurement Model
8.7 Self-amplifying RNA (saRNA) Drugs Industry Sales Model and Sales Channels
8.7.1 Self-amplifying RNA (saRNA) Drugs Sales Model
8.7.2 Self-amplifying RNA (saRNA) Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Self-amplifying RNA (saRNA) Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Self-amplifying RNA (saRNA) Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2019-2024)
Table 9. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2025-2030)
Table 10. World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Self-amplifying RNA (saRNA) Drugs Major Market Trends
Table 13. World Self-amplifying RNA (saRNA) Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Self-amplifying RNA (saRNA) Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Self-amplifying RNA (saRNA) Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Self-amplifying RNA (saRNA) Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Self-amplifying RNA (saRNA) Drugs Producers in 2023
Table 18. World Self-amplifying RNA (saRNA) Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Self-amplifying RNA (saRNA) Drugs Producers in 2023
Table 20. World Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Self-amplifying RNA (saRNA) Drugs Company Evaluation Quadrant
Table 22. World Self-amplifying RNA (saRNA) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Self-amplifying RNA (saRNA) Drugs Production Site of Key Manufacturer
Table 24. Self-amplifying RNA (saRNA) Drugs Market: Company Product Type Footprint
Table 25. Self-amplifying RNA (saRNA) Drugs Market: Company Product Application Footprint
Table 26. Self-amplifying RNA (saRNA) Drugs Competitive Factors
Table 27. Self-amplifying RNA (saRNA) Drugs New Entrant and Capacity Expansion Plans
Table 28. Self-amplifying RNA (saRNA) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Self-amplifying RNA (saRNA) Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Self-amplifying RNA (saRNA) Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Self-amplifying RNA (saRNA) Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 37. China Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 47. World Self-amplifying RNA (saRNA) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Self-amplifying RNA (saRNA) Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Self-amplifying RNA (saRNA) Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Self-amplifying RNA (saRNA) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Self-amplifying RNA (saRNA) Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Self-amplifying RNA (saRNA) Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Chimeron Bio Basic Information, Manufacturing Base and Competitors
Table 62. Chimeron Bio Major Business
Table 63. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product and Services
Table 64. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Chimeron Bio Recent Developments/Updates
Table 66. Chimeron Bio Competitive Strengths & Weaknesses
Table 67. Ziphius Vaccines Basic Information, Manufacturing Base and Competitors
Table 68. Ziphius Vaccines Major Business
Table 69. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product and Services
Table 70. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Ziphius Vaccines Recent Developments/Updates
Table 72. Ziphius Vaccines Competitive Strengths & Weaknesses
Table 73. Aldevron Basic Information, Manufacturing Base and Competitors
Table 74. Aldevron Major Business
Table 75. Aldevron Self-amplifying RNA (saRNA) Drugs Product and Services
Table 76. Aldevron Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Aldevron Recent Developments/Updates
Table 78. Aldevron Competitive Strengths & Weaknesses
Table 79. VaxEquity Basic Information, Manufacturing Base and Competitors
Table 80. VaxEquity Major Business
Table 81. VaxEquity Self-amplifying RNA (saRNA) Drugs Product and Services
Table 82. VaxEquity Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. VaxEquity Recent Developments/Updates
Table 84. VaxEquity Competitive Strengths & Weaknesses
Table 85. Precision Nanosystems Basic Information, Manufacturing Base and Competitors
Table 86. Precision Nanosystems Major Business
Table 87. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product and Services
Table 88. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Precision Nanosystems Recent Developments/Updates
Table 90. Precision Nanosystems Competitive Strengths & Weaknesses
Table 91. Replicate Bioscience Basic Information, Manufacturing Base and Competitors
Table 92. Replicate Bioscience Major Business
Table 93. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product and Services
Table 94. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Replicate Bioscience Recent Developments/Updates
Table 96. Replicate Bioscience Competitive Strengths & Weaknesses
Table 97. Elixirgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Elixirgen Therapeutics Major Business
Table 99. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
Table 100. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Elixirgen Therapeutics Recent Developments/Updates
Table 102. Elixirgen Therapeutics Competitive Strengths & Weaknesses
Table 103. Immorna Basic Information, Manufacturing Base and Competitors
Table 104. Immorna Major Business
Table 105. Immorna Self-amplifying RNA (saRNA) Drugs Product and Services
Table 106. Immorna Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Immorna Recent Developments/Updates
Table 108. Immorna Competitive Strengths & Weaknesses
Table 109. CSL Basic Information, Manufacturing Base and Competitors
Table 110. CSL Major Business
Table 111. CSL Self-amplifying RNA (saRNA) Drugs Product and Services
Table 112. CSL Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. CSL Recent Developments/Updates
Table 114. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 115. Arcturus Therapeutics Major Business
Table 116. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
Table 117. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Self-amplifying RNA (saRNA) Drugs Upstream (Raw Materials)
Table 119. Self-amplifying RNA (saRNA) Drugs Typical Customers
Table 120. Self-amplifying RNA (saRNA) Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Self-amplifying RNA (saRNA) Drugs Picture
Figure 2. World Self-amplifying RNA (saRNA) Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Self-amplifying RNA (saRNA) Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 5. World Self-amplifying RNA (saRNA) Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 10. China Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 12. Self-amplifying RNA (saRNA) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Self-amplifying RNA (saRNA) Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Self-amplifying RNA (saRNA) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Self-amplifying RNA (saRNA) Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Self-amplifying RNA (saRNA) Drugs Markets in 2023
Figure 26. United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Self-amplifying RNA (saRNA) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 32. World Self-amplifying RNA (saRNA) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Type in 2023
Figure 34. Preventive Medicine
Figure 35. Medicine
Figure 36. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Type (2019-2030)
Figure 37. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Self-amplifying RNA (saRNA) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Application in 2023
Figure 41. Infectious Disease
Figure 42. Cancer
Figure 43. Others
Figure 44. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Application (2019-2030)
Figure 45. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Application (2019-2030)
Figure 46. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Self-amplifying RNA (saRNA) Drugs Industry Chain
Figure 48. Self-amplifying RNA (saRNA) Drugs Procurement Model
Figure 49. Self-amplifying RNA (saRNA) Drugs Sales Model
Figure 50. Self-amplifying RNA (saRNA) Drugs Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Self-amplifying RNA (saRNA) Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Self-amplifying RNA (saRNA) Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Self-amplifying RNA (saRNA) Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2019-2024)
Table 9. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2025-2030)
Table 10. World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Self-amplifying RNA (saRNA) Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Self-amplifying RNA (saRNA) Drugs Major Market Trends
Table 13. World Self-amplifying RNA (saRNA) Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Self-amplifying RNA (saRNA) Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Self-amplifying RNA (saRNA) Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Self-amplifying RNA (saRNA) Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Self-amplifying RNA (saRNA) Drugs Producers in 2023
Table 18. World Self-amplifying RNA (saRNA) Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Self-amplifying RNA (saRNA) Drugs Producers in 2023
Table 20. World Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Self-amplifying RNA (saRNA) Drugs Company Evaluation Quadrant
Table 22. World Self-amplifying RNA (saRNA) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Self-amplifying RNA (saRNA) Drugs Production Site of Key Manufacturer
Table 24. Self-amplifying RNA (saRNA) Drugs Market: Company Product Type Footprint
Table 25. Self-amplifying RNA (saRNA) Drugs Market: Company Product Application Footprint
Table 26. Self-amplifying RNA (saRNA) Drugs Competitive Factors
Table 27. Self-amplifying RNA (saRNA) Drugs New Entrant and Capacity Expansion Plans
Table 28. Self-amplifying RNA (saRNA) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Self-amplifying RNA (saRNA) Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Self-amplifying RNA (saRNA) Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Self-amplifying RNA (saRNA) Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 37. China Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Self-amplifying RNA (saRNA) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share (2019-2024)
Table 47. World Self-amplifying RNA (saRNA) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Self-amplifying RNA (saRNA) Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Self-amplifying RNA (saRNA) Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Self-amplifying RNA (saRNA) Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Self-amplifying RNA (saRNA) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Self-amplifying RNA (saRNA) Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Self-amplifying RNA (saRNA) Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Self-amplifying RNA (saRNA) Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Chimeron Bio Basic Information, Manufacturing Base and Competitors
Table 62. Chimeron Bio Major Business
Table 63. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product and Services
Table 64. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Chimeron Bio Recent Developments/Updates
Table 66. Chimeron Bio Competitive Strengths & Weaknesses
Table 67. Ziphius Vaccines Basic Information, Manufacturing Base and Competitors
Table 68. Ziphius Vaccines Major Business
Table 69. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product and Services
Table 70. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Ziphius Vaccines Recent Developments/Updates
Table 72. Ziphius Vaccines Competitive Strengths & Weaknesses
Table 73. Aldevron Basic Information, Manufacturing Base and Competitors
Table 74. Aldevron Major Business
Table 75. Aldevron Self-amplifying RNA (saRNA) Drugs Product and Services
Table 76. Aldevron Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Aldevron Recent Developments/Updates
Table 78. Aldevron Competitive Strengths & Weaknesses
Table 79. VaxEquity Basic Information, Manufacturing Base and Competitors
Table 80. VaxEquity Major Business
Table 81. VaxEquity Self-amplifying RNA (saRNA) Drugs Product and Services
Table 82. VaxEquity Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. VaxEquity Recent Developments/Updates
Table 84. VaxEquity Competitive Strengths & Weaknesses
Table 85. Precision Nanosystems Basic Information, Manufacturing Base and Competitors
Table 86. Precision Nanosystems Major Business
Table 87. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product and Services
Table 88. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Precision Nanosystems Recent Developments/Updates
Table 90. Precision Nanosystems Competitive Strengths & Weaknesses
Table 91. Replicate Bioscience Basic Information, Manufacturing Base and Competitors
Table 92. Replicate Bioscience Major Business
Table 93. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product and Services
Table 94. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Replicate Bioscience Recent Developments/Updates
Table 96. Replicate Bioscience Competitive Strengths & Weaknesses
Table 97. Elixirgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. Elixirgen Therapeutics Major Business
Table 99. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
Table 100. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Elixirgen Therapeutics Recent Developments/Updates
Table 102. Elixirgen Therapeutics Competitive Strengths & Weaknesses
Table 103. Immorna Basic Information, Manufacturing Base and Competitors
Table 104. Immorna Major Business
Table 105. Immorna Self-amplifying RNA (saRNA) Drugs Product and Services
Table 106. Immorna Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Immorna Recent Developments/Updates
Table 108. Immorna Competitive Strengths & Weaknesses
Table 109. CSL Basic Information, Manufacturing Base and Competitors
Table 110. CSL Major Business
Table 111. CSL Self-amplifying RNA (saRNA) Drugs Product and Services
Table 112. CSL Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. CSL Recent Developments/Updates
Table 114. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 115. Arcturus Therapeutics Major Business
Table 116. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product and Services
Table 117. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Self-amplifying RNA (saRNA) Drugs Upstream (Raw Materials)
Table 119. Self-amplifying RNA (saRNA) Drugs Typical Customers
Table 120. Self-amplifying RNA (saRNA) Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Self-amplifying RNA (saRNA) Drugs Picture
Figure 2. World Self-amplifying RNA (saRNA) Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Self-amplifying RNA (saRNA) Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 5. World Self-amplifying RNA (saRNA) Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 10. China Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Self-amplifying RNA (saRNA) Drugs Production (2019-2030) & (K Units)
Figure 12. Self-amplifying RNA (saRNA) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Self-amplifying RNA (saRNA) Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Self-amplifying RNA (saRNA) Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Self-amplifying RNA (saRNA) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Self-amplifying RNA (saRNA) Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Self-amplifying RNA (saRNA) Drugs Markets in 2023
Figure 26. United States VS China: Self-amplifying RNA (saRNA) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Self-amplifying RNA (saRNA) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Self-amplifying RNA (saRNA) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Self-amplifying RNA (saRNA) Drugs Production Market Share 2023
Figure 32. World Self-amplifying RNA (saRNA) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Type in 2023
Figure 34. Preventive Medicine
Figure 35. Medicine
Figure 36. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Type (2019-2030)
Figure 37. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Self-amplifying RNA (saRNA) Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Self-amplifying RNA (saRNA) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Application in 2023
Figure 41. Infectious Disease
Figure 42. Cancer
Figure 43. Others
Figure 44. World Self-amplifying RNA (saRNA) Drugs Production Market Share by Application (2019-2030)
Figure 45. World Self-amplifying RNA (saRNA) Drugs Production Value Market Share by Application (2019-2030)
Figure 46. World Self-amplifying RNA (saRNA) Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Self-amplifying RNA (saRNA) Drugs Industry Chain
Figure 48. Self-amplifying RNA (saRNA) Drugs Procurement Model
Figure 49. Self-amplifying RNA (saRNA) Drugs Sales Model
Figure 50. Self-amplifying RNA (saRNA) Drugs Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
